Urology Market Market Report Suite - Brazil - 2020-2026 - MedSuite

Urology Market Market Report Suite - Brazil - 2020-2026 - MedSuite

Throughout this medical market research, iData Research analyzed 54 urology companies in Brazil and utilized thier comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the Brazilian Urological Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research offers a urological procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered

• Procedure Numbers for Urological Devices in Brazil – MedPro
• Urinary Incontinence Market - MedCore
• Pelvic Organ Prolapse Repair Market - MedCore
• Stone Management Market - MedCore
• BPH Treatment Market - MedCore
• Erectile Dysfunction Market - MedCore

Brazilian Urology Market Insights

The primary limiter of many of these urological device markets is the increasing use of pharmaceutical treatments. For instance, both stone management and BPH device markets, the largest segments in this report, are limited tremendously by drug therapy. In 2018, over 90% of BPH patients received drug therapy treatment over interventional methods. While drugs do not solve the underlying problem of either prostate or stone growth, they do reduce the severity of symptoms, which allows patients to delay or avoid surgery.

BPH is prevalent among men over the age of 50 years. Prevalence increases with age, reaching figures of 85% to 90% for men above the age of 80. Brazil is aging at record highs. By 2050, Brazil will have around 66 million people above the age 60 living in its territory, or three times more than the 24 million today. As the elderly population continues to increase, due tothe aging baby boom population, the BPH incidence rate is expected to rise. This will help drive the BPH treatment market growth for the near future.

Overall, the Brazilian urological device market was valued at $663.6 million in 2019. This is expected to increase over the forecast period at a CAGR of 2.8% to reach $806 million.

The full report suite on the Brazilian market for urological devices includes urinary incontinence devices, pelvic organ prolapse repair (POP) devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices and erectile dysfunction devices.